Clinically relevant drug interactions with antiretroviral drugs;Klinisch relevante geneesmiddelinteracties met antiretrovirale geneesmiddelen

Pharmaceutisch Weekblad

Volumn 131, Issue 43, 1996, Pages 1232-1234

  Burger, D M ^a   Hoetelmans, R M W ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; ASTEMIZOLE; CALCIUM ANTAGONIST; CIPROFLOXACIN; CISAPRIDE; CLARITHROMYCIN; CYCLOSPORIN A; DIDANOSINE; ERGOTAMINE; GANCICLOVIR; INDINAVIR; LAMIVUDINE; MIDAZOLAM; NEVIRAPINE; ORAL CONTRACEPTIVE AGENT; PIROXICAM; QUINIDINE; RIFAMPICIN; RITONAVIR; STAVUDINE; TERFENADINE; TRIAZOLAM; UNINDEXED DRUG; WARFARIN; ZALCITABINE; ZIDOVUDINE;

DRUG CHOICE; DRUG CONTRAINDICATION; DRUG INTERACTION; HUMAN; SHORT SURVEY;

EID: 0029803724     PISSN: 00316911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (1)

1. Verzijl JM, Van den Bemt PMLA, Lenderink AW. Distributie van nieuwe antiretrovirale middelen langs nieuwe wegen - een eerste reactie. Pharm Weekbl 1996;131(34):962-4.